These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16903132)

  • 1. Estrogen and performance in recognition memory for olfactory and visual stimuli in females diagnosed with Alzheimer's disease.
    Sundermann E; Gilbert PE; Murphy C
    J Int Neuropsychol Soc; 2006 May; 12(3):400-4. PubMed ID: 16903132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls.
    Gilbert PE; Murphy C
    J Clin Exp Neuropsychol; 2004 Sep; 26(6):779-94. PubMed ID: 15370375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4.
    Burkhardt MS; Foster JK; Laws SM; Baker LD; Craft S; Gandy SE; Stuckey BG; Clarnette R; Nolan D; Hewson-Bower B; Martins RN
    J Alzheimers Dis; 2004 Jun; 6(3):221-8. PubMed ID: 15201477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in olfactory and visual memory in patients with pathologically confirmed Alzheimer's disease and the Lewy body variant of Alzheimer's disease.
    Gilbert PE; Barr PJ; Murphy C
    J Int Neuropsychol Soc; 2004 Oct; 10(6):835-42. PubMed ID: 15637774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and cognitive functioning in women.
    Sherwin BB
    Endocr Rev; 2003 Apr; 24(2):133-51. PubMed ID: 12700177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect?
    Resnick SM; Metter EJ; Zonderman AB
    Neurology; 1997 Dec; 49(6):1491-7. PubMed ID: 9409335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.
    Sedghizadeh MJ; Hojjati H; Ezzatdoost K; Aghajan H; Vahabi Z; Tarighatnia H
    PLoS One; 2020; 15(12):e0243535. PubMed ID: 33320870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women.
    Doty RL; Tourbier I; Ng V; Neff J; Armstrong D; Battistini M; Sammel MD; Gettes D; Evans DL; Mirza N; Moberg PJ; Connolly T; Sondheimer SJ
    Neurobiol Aging; 2015 Jun; 36(6):2053-9. PubMed ID: 25850354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease.
    Greene RA
    Int J Fertil Womens Med; 2000; 45(4):253-7. PubMed ID: 10997480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy to maintain cognitive function in women with dementia.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risks and benefits of estrogen replacement therapy: Leisure World.
    Paganini-Hill A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term odor recognition memory in unipolar major depression and Alzheimer׳s disease.
    Naudin M; Mondon K; El-Hage W; Desmidt T; Jaafari N; Belzung C; Gaillard P; Hommet C; Atanasova B
    Psychiatry Res; 2014 Dec; 220(3):861-6. PubMed ID: 25262560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease.
    Seshadri S; Zornberg GL; Derby LE; Myers MW; Jick H; Drachman DA
    Arch Neurol; 2001 Mar; 58(3):435-40. PubMed ID: 11255447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging.
    Kawas C; Resnick S; Morrison A; Brookmeyer R; Corrada M; Zonderman A; Bacal C; Lingle DD; Metter E
    Neurology; 1997 Jun; 48(6):1517-21. PubMed ID: 9191758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review.
    Zec RF; Trivedi MA
    Neuropsychol Rev; 2002 Jun; 12(2):65-109. PubMed ID: 12371603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between recognition memory and remote memory for olfactory and visual stimuli in nondemented elderly individuals genetically at risk for Alzheimer's disease.
    Gilbert PE; Murphy C
    Exp Gerontol; 2004 Mar; 39(3):433-41. PubMed ID: 15036403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory ERPs in an odor/visual congruency task differentiate ApoE ε4 carriers from non-carriers.
    Kowalewski J; Murphy C
    Brain Res; 2012 Mar; 1442():55-65. PubMed ID: 22305338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Odor memory in normal aging and Alzheimer's disease.
    Nordin S; Murphy C
    Ann N Y Acad Sci; 1998 Nov; 855():686-93. PubMed ID: 9929672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.